FERNANDO
ALFONSO MANTEROLA
Investigador en el periodo 2008-2013
Hospital Universitario Puerta de Hierro
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (16)
2024
-
A Prospective, Multicenter, Real-World Registry of Coronary Lithotripsy in Calcified Coronary Arteries: The REPLICA-EPIC18 Study
JACC: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 756-767
2023
-
Cardiac Death After Transcatheter Aortic Valve Replacement With Contemporary Devices
JACC: Cardiovascular Interventions, Vol. 16, Núm. 18, pp. 2277-2290
-
Optimal Degree of Balloon-Expandable Transcatheter Valve Oversizing in Patients With Borderline Aortic Annulus Measurements: Insights From a Multicenter Real-World Experience
Circulation: Cardiovascular Interventions, Vol. 16, Núm. 3, pp. E012554
2022
-
Frailty and prognosis of older patients with chronic heart failure
Revista Espanola de Cardiologia, Vol. 75, Núm. 12, pp. 1011-1019
-
Sex differences in the impact of frailty in elderly outpatients with heart failure
Frontiers in Cardiovascular Medicine, Vol. 9
-
Transcatheter versus surgical aortic valve replacement in patients with morbid obesity: a multicentre propensity score-matched analysis
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 5, pp. e417-e427
2021
-
Age and Gender influence on time of arrival for STEMI patients during Covid-19 pandemic
American Journal of Emergency Medicine
-
Impact of morbid obesity and obesity phenotype on outcomes after transcatheter aortic valve replacement
Journal of the American Heart Association, Vol. 10, Núm. 12
2018
-
3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents
JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991
2016
-
Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention
Journal of the American College of Cardiology, Vol. 67, Núm. 23, pp. 2705-2715
2015
-
A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis of Drug-Eluting Stents the RIBS IV Randomized Clinical Trial
Journal of the American College of Cardiology, Vol. 66, Núm. 1, pp. 23-33
-
Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis)
EuroIntervention, Vol. 11, Núm. 3, pp. 336-342
2014
-
A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: The RIBS v clinical trial (restenosis intra-stent of bare metal stents: Paclitaxel-eluting balloon vs. everolimus-eluting stent)
Journal of the American College of Cardiology, Vol. 63, Núm. 14, pp. 1378-1386
2013
-
Comparison of paclitaxel-eluting stents (Taxus) and everolimus-eluting stents (Xience) in left main coronary artery disease with 3 years follow-up (from the ESTROFA-LM registry)
American Journal of Cardiology, Vol. 111, Núm. 5, pp. 676-683
-
Mortalidad intrahospitalaria por infarto agudo de miocardio. Relevancia del tipo de hospital y la atención dispensada. Estudio RECALCAR
Revista Espanola de Cardiologia, Vol. 66, Núm. 12, pp. 935-942